TrialJournal of surgical oncology2022

High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancer.

Jennifer A Crozier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.